As of 2025-01-24, the Relative Valuation of MacroGenics Inc (MGNX) is (27.53) USD. This relative valuation is based on P/E multiples. With the latest stock price at 3.16 USD, the upside of MacroGenics Inc based on Relative Valuation is -971.2%.
The range of the Relative Valuation is (28.99) - (43.15) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 15.6x - 27.7x | 16.4x |
| Forward P/E multiples | 18.6x - 30.3x | 19.0x |
| Fair Price | (28.99) - (43.15) | (27.53) |
| Upside | -1017.5% - -1465.4% | -971.2% |
| Date | P/E |
| 2025-01-23 | -2.01 |
| 2025-01-22 | -1.98 |
| 2025-01-21 | -1.93 |
| 2025-01-17 | -1.93 |
| 2025-01-16 | -1.95 |
| 2025-01-15 | -2.05 |
| 2025-01-14 | -1.95 |
| 2025-01-13 | -2.04 |
| 2025-01-10 | -2.04 |
| 2025-01-08 | -2.15 |
| 2025-01-07 | -2.19 |
| 2025-01-06 | -2.24 |
| 2025-01-03 | -2.22 |
| 2025-01-02 | -2.12 |
| 2024-12-31 | -2.09 |
| 2024-12-30 | -2.08 |
| 2024-12-27 | -2.08 |
| 2024-12-26 | -2.10 |
| 2024-12-24 | -2.10 |
| 2024-12-23 | -2.08 |
| 2024-12-20 | -2.04 |
| 2024-12-19 | -2.04 |
| 2024-12-18 | -2.06 |
| 2024-12-17 | -2.15 |
| 2024-12-16 | -2.08 |
| 2024-12-13 | -2.06 |
| 2024-12-12 | -2.19 |
| 2024-12-11 | -2.19 |
| 2024-12-10 | -2.15 |
| 2024-12-09 | -2.24 |
| 2024-12-06 | -2.25 |
| 2024-12-05 | -2.18 |
| 2024-12-04 | -2.24 |
| 2024-12-03 | -2.21 |
| 2024-12-02 | -2.37 |
| 2024-11-29 | -2.31 |
| 2024-11-27 | -2.34 |
| 2024-11-26 | -2.19 |
| 2024-11-25 | -2.12 |
| 2024-11-22 | -2.08 |
| 2024-11-21 | -2.06 |
| 2024-11-20 | -2.11 |
| 2024-11-19 | -2.24 |
| 2024-11-18 | -2.26 |
| 2024-11-15 | -2.30 |
| 2024-11-14 | -2.45 |
| 2024-11-13 | -2.42 |
| 2024-11-12 | -2.64 |
| 2024-11-11 | -2.82 |
| 2024-11-08 | -2.80 |